Search Results - "Rodríguez, Claudia Cárcamo"
-
1
Secondary paroxysmal dyskinesia in multiple sclerosis: Clinical–radiological features and treatment. Case report of seven patients
Published in Multiple sclerosis (01-11-2017)“…Secondary paroxysmal dyskinesias (SPDs) are short, episodic, and recurrent movement disorders, classically related to multiple sclerosis (MS). Carbamazepine is…”
Get full text
Journal Article -
2
Prevalence of epilepsy in a cohort of patients with multiple sclerosis
Published in Seizure (London, England) (01-01-2014)“…Abstract Introduction Epilepsy prevalence is 0.27–1.7% in general population. However, higher figures have been reported in Multiple Sclerosis (MS) patients,…”
Get full text
Journal Article -
3
Social cognition: Concepts, neural basis and its role in multiple sclerosis
Published in Neurology and clinical neuroscience (01-01-2018)“…Social cognition, including social perception, empathy and theory of mind, focuses on how people process, store, and apply information about other people and…”
Get full text
Journal Article -
4
Biological and nonbiological complex drugs for multiple sclerosis in Latin America: regulations and risk management
Published in Expert review of neurotherapeutics (01-06-2015)“…Biological drugs and nonbiological complex drugs with expired patents are followed by biosimilars and follow-on drugs that are supposedly similar and…”
Get more information
Journal Article -
5
Ensayo pictórico: Diagnóstico diferencial radiológico en Esclerosis Múltiple
Published in Revista chilena de radiología (01-03-2019)“…Resumen: La esclerosis múltiple (EM) es la enfermedad inflamatorio-desmielinizante del Sistema nervioso central más prevalente en adultos. La resonancia…”
Get full text
Journal Article -
6
Ensayo pictórico: Diagnóstico diferencial radiológico en Esclerosis Múltiple
Published in Revista chilena de radiología (01-03-2019)Get full text
Journal Article -
7
Imágenes de resonancia magnética funcional en el estudio de la esclerosis múltiple
Published in Revista de neurologiá (01-08-2018)Get full text
Journal Article -
8
Use of Fingolimod in the Management of Relapsing–Remitting Multiple Sclerosis: Experience from Latin America
Published in Advances in therapy (01-07-2015)“…Once-daily fingolimod 0.5 mg (FTY720; Gilenya ® , Novartis Pharma AG, Basel, Switzerland) is a sphingosine 1-phosphate receptor modulator that is approved for…”
Get full text
Journal Article -
9
Espectro de neuromielitis óptica: descripción de una cohorte según los criterios diagnósticos de 2015
Published in Revista de neurologiá (01-09-2017)Get full text
Journal Article -
10
Practical Issues Concerning the Approval and Use of Biosimilar Drugs for the Treatment of Multiple Sclerosis in Latin America
Published in Neurology and therapy (01-12-2019)“…The use of biosimilar drugs for multiple sclerosis (MS) has become widespread in Latin America, with the goal of reducing costs of treatments, promoting the…”
Get full text
Journal Article -
11
Differences in Pharmacovigilance Regulatory Requirements in Latin America countries (LATAM): impact in the real world experience (2464)
Published in Neurology (14-04-2020)“…Abstract only…”
Get full text
Journal Article